Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mol Pharmacol
2009 Oct 01;764:754-65. doi: 10.1124/mol.109.057687.
Show Gene links
Show Anatomy links
Photodynamic effects of steroid-conjugated fluorophores on GABAA receptors.
Shu HJ
,
Eisenman LN
,
Wang C
,
Bandyopadhyaya AK
,
Krishnan K
,
Taylor A
,
Benz AM
,
Manion B
,
Evers AS
,
Covey DF
,
Zorumski CF
,
Mennerick S
.
???displayArticle.abstract???
We have shown that fluorescent, 7-nitro-2,1,3-benzoxadiazol-4-yl amino (NBD)-conjugated neurosteroid analogs photopotentiate GABA(A) receptor function. These compounds seem to photosensitize a modification of receptor function, resulting in long-lived increases in responses to exogenous or synaptic GABA. Here we extend this work to examine the effectiveness of different fluorophore positions, conjugations, steroid structures, and fluorophores. Our results are generally in agreement with the idea that steroids with activity at GABA(A) receptors are the most potent photopotentiators. In particular, we find that an unnatural enantiomer of an effective photopotentiating steroid is relatively weak, excluding the idea that membrane solubility alone, which is identical for enantiomer pairs, is solely responsible for potent photopotentiation. Furthermore, there is a significant correlation between baseline GABA(A) receptor activity and photopotentiation. Curiously, both sulfated steroids, which bind a presumed external neurosteroid antagonist site, and hydroxysteroids, which bind an independent site, are effective. We also find that a rhodamine dye conjugated to a 5beta-reduced 3alpha-hydroxy steroid is a particularly potent and effective photopotentiator, with minimal baseline receptor activity up to 10 muM. Steroid conjugated fluorescein and Alexa Fluor 546 also supported photopotentiation, although the Alexa Fluor conjugate was weaker and required 10-fold higher concentration to achieve similar potentiation to the best NBD and rhodamine conjugates. Filling cells with steroid-conjugated or free fluorophores via whole-cell patch pipette did not support photopotentiation. FM1-43, another membrane-targeted, structurally unrelated fluorophore, also produced photopotentiation at micromolar concentrations. We conclude that further optimization of fluorophore and carrier could produce an effective, selective, light-sensitive GABA(A) receptor modulator.
Akk,
Neurosteroid access to the GABAA receptor.
2005, Pubmed
Akk,
Neurosteroid access to the GABAA receptor.
2005,
Pubmed
Amato,
Modulation of neuronal and recombinant GABAA receptors by redox reagents.
1999,
Pubmed
Antic,
Fast optical recordings of membrane potential changes from dendrites of pyramidal neurons.
1999,
Pubmed
Belelli,
The influence of subunit composition on the interaction of neurosteroids with GABA(A) receptors.
2002,
Pubmed
,
Xenbase
Betz,
Optical analysis of synaptic vesicle recycling at the frog neuromuscular junction.
1992,
Pubmed
Chang,
Positive allosteric modulation by ultraviolet irradiation on GABA(A), but not GABA(C), receptors expressed in Xenopus oocytes.
2001,
Pubmed
,
Xenbase
Covey,
Enantioselectivity of pregnanolone-induced gamma-aminobutyric acid(A) receptor modulation and anesthesia.
2000,
Pubmed
Covey,
Recent developments in structure-activity relationships for steroid modulators of GABA(A) receptors.
2001,
Pubmed
Deisseroth,
Next-generation optical technologies for illuminating genetically targeted brain circuits.
2006,
Pubmed
Dolmans,
Photodynamic therapy for cancer.
2003,
Pubmed
Eisenman,
Anticonvulsant and anesthetic effects of a fluorescent neurosteroid analog activated by visible light.
2007,
Pubmed
Eisenman,
NMDA potentiation by visible light in the presence of a fluorescent neurosteroid analogue.
2009,
Pubmed
Gradinaru,
Optical deconstruction of parkinsonian neural circuitry.
2009,
Pubmed
Han,
Millisecond-timescale optical control of neural dynamics in the nonhuman primate brain.
2009,
Pubmed
Harrison,
Structure-activity relationships for steroid interaction with the gamma-aminobutyric acidA receptor complex.
1987,
Pubmed
Hawkinson,
The neuroactive steroid 3 alpha-hydroxy-5 beta-pregnan-20-one is a two-component modulator of ligand binding to the GABAA receptor.
1994,
Pubmed
Helmchen,
Deep tissue two-photon microscopy.
2005,
Pubmed
Leszkiewicz,
A role for the redox site in the modulation of the NMDA receptor by light.
2002,
Pubmed
Leszkiewicz,
Reversible modulation of GABA(A) receptor-mediated currents by light is dependent on the redox state of the receptor.
2003,
Pubmed
Maksay,
Allosteric modulators affect the efficacy of partial agonists for recombinant GABA(A) receptors.
2000,
Pubmed
,
Xenbase
Mennerick,
Passive and synaptic properties of hippocampal neurons grown in microcultures and in mass cultures.
1995,
Pubmed
Mennerick,
Selective antagonism of 5alpha-reduced neurosteroid effects at GABA(A) receptors.
2004,
Pubmed
,
Xenbase
Pan,
Redox modulation of recombinant human GABA(A) receptors.
2000,
Pubmed
,
Xenbase
Pan,
Differential modulation by sulfhydryl redox agents and glutathione of GABA- and glycine-evoked currents in rat retinal ganglion cells.
1995,
Pubmed
Park-Chung,
Sulfated and unsulfated steroids modulate gamma-aminobutyric acidA receptor function through distinct sites.
1999,
Pubmed
,
Xenbase
Rudolph,
GABA-based therapeutic approaches: GABAA receptor subtype functions.
2006,
Pubmed
Shu,
Slow actions of neuroactive steroids at GABAA receptors.
2004,
Pubmed
,
Xenbase
Sjulson,
Photocontrol of neural activity: biophysical mechanisms and performance in vivo.
2008,
Pubmed
Wang,
3beta -hydroxypregnane steroids are pregnenolone sulfate-like GABA(A) receptor antagonists.
2002,
Pubmed
,
Xenbase
Wittmer,
Enantioselectivity of steroid-induced gamma-aminobutyric acidA receptor modulation and anesthesia.
1996,
Pubmed
,
Xenbase
Wohlfarth,
Enhanced neurosteroid potentiation of ternary GABA(A) receptors containing the delta subunit.
2002,
Pubmed
Zeng,
Neurosteroid analogues. 10. The effect of methyl group substitution at the C-6 and C-7 positions on the GABA modulatory and anesthetic actions of (3alpha,5alpha)- and (3alpha,5beta)-3-hydroxypregnan-20-one.
2005,
Pubmed
,
Xenbase